ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
3.12
-0.07 (-2.19%)
At close: Aug 15, 2025, 10:20 AM
-2.19% (1D)
| Bid | 3.11 |
| Market Cap | 350.43M |
| Revenue (ttm) | 70.19M |
| Net Income (ttm) | -149.84M |
| EPS (ttm) | -1.55 |
| PE Ratio (ttm) | -2.01 |
| Forward PE | -2.04 |
| Analyst | Buy |
| Ask | 3.13 |
| Volume | 128,186 |
| Avg. Volume (20D) | 819,527 |
| Open | 3.21 |
| Previous Close | 3.19 |
| Day's Range | 3.10 - 3.21 |
| 52-Week Range | 1.05 - 3.97 |
| Beta | 1.93 |
About ADCT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ADCT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ADCT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
ADC Therapeutics S.A. has released their quartely earnings
on Aug 12, 2025:
Next Earnings Release
ADC Therapeutics S.A. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-8.58%
ADC Therapeutics shares are trading lower after RB...
Unlock content with
Pro Subscription
3 months ago
+37.12%
ADC Therapeutics shares are trading higher after the company reported Q1 financial results and beat its adjusted EPS and revenue estimates.
